Search Results - "GANDA, O. P"

Refine Results
  1. 1

    Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia by Ganda, O.P, Jumes, C.G, Abrahamson, M.J, Molla, M

    Published in Diabetes research and clinical practice (01-07-2012)
    “…Abstract Aims In patients with diabetes and hypertriglyceridemia, LDL-cholesterol (LDL-C) provides an inaccurate reflection of LDL particle burden. The…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes by GANDA, O. P, ARKIN, C. F

    Published in Diabetes care (01-10-1992)
    “…Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. O P Ganda and C F Arkin Joslin Diabetes Center, Boston, MA 02215…”
    Get full text
    Journal Article
  4. 4

    Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose by SRIKANTA, S, GANDA, O. P, GLEASON, R. E, JACKSON, R. A, SOELDNER, J. S, EISENBARTH, G. S

    Published in Diabetes (New York, N.Y.) (01-08-1984)
    “…Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. S Srikanta , O P Ganda , R E Gleason , R A Jackson , J S Soeldner and G S…”
    Get full text
    Journal Article
  5. 5

    First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion by Srikanta, S, Ganda, O P, Rabizadeh, A, Soeldner, J S, Eisenbarth, G S

    Published in The New England journal of medicine (22-08-1985)
    “…In a prospective study to evaluate the prevalence and predictive potential of circulating islet-cell antibodies, we have screened 1723 "normal" first-degree…”
    Get more information
    Journal Article
  6. 6

    Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction by Srikanta, S, Ganda, O P, Jackson, R A, Gleason, R E, Kaldany, A, Garovoy, M R, Milford, E L, Carpenter, C B, Soeldner, J S, Eisenbarth, G S

    Published in Annals of internal medicine (01-09-1983)
    “…In a prospective 21-year study, islet cell antibodies and beta cell function were serially assessed in 24 monozygotic twins initially discordant for type I…”
    Get more information
    Journal Article
  7. 7

    Differential sensitivity to β-cell secretagogues in early, type I diabetes mellitus by GANDA, O. P, SRIKANTA, S, BRINK, S. J, MORRIS, M. A, GLEASON, R. E, SOELDNER, J. S, EISENBARTH, G. S

    Published in Diabetes (New York, N.Y.) (01-06-1984)
    “…The insulin secretory response to various beta-cell secretagogues was studied in four children (ages 11, 11, 12, and 10 yr) in "early" stages or remission of…”
    Get full text
    Journal Article
  8. 8

    Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia by Raskin, P, Ganda, O P, Schwartz, S, Willard, D, Rosenstock, J, Lodewick, P A, Cressman, M D, Phillipson, B, Weiner, B, McGovern, M E

    Published in The American journal of medicine (01-10-1995)
    “…Patients with type I and type II diabetes mellitus have an increased risk of coronary heart disease. In many diabetics, hypercholesterolemia is present and…”
    Get more information
    Journal Article
  9. 9

    Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus by Ganda, O. P., Srikanta, S., Brink, S. J., Morris, M. A., Gleason, R. E., Soeldner, J. S., Eisenbarth, G. S.

    Published in Diabetes (New York, N.Y.) (01-06-1984)
    “…Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. O P Ganda , S Srikanta , S J Brink , M A Morris , R E Gleason , J S…”
    Get full text
    Journal Article
  10. 10

    Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics by Christlieb, A R, Warram, J H, Królewski, A S, Busick, E J, Ganda, O P, Asmal, A C, Soeldner, J S, Bradley, R F

    Published in Diabetes (New York, N.Y.) (01-01-1981)
    “…The prevalence of hypertension in various age groups of diabetics and its role as a risk factor in juvenileonset insulin-dependent diabetics followed for 40 yr…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus by Ganda, O P

    Published in Diabetes care (01-05-1981)
    “…The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus. O P Ganda Abstract The pancreatic islet hormone secretion is…”
    Get full text
    Journal Article
  15. 15

    Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents by Ganda, O P, Soeldner, J S, Gleason, R E

    Published in Diabetes care (01-05-1985)
    “…Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents. O P Ganda , J S Soeldner and R E…”
    Get full text
    Journal Article
  16. 16

    Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus by Brown, F M, Vinik, A I, Ganda, O P, Adri, M N, Rabinowe, S L

    Published in Hormone and metabolic research (01-08-1989)
    “…Autoimmunity is a known factor in the pathogenesis of islet cell destruction, but little is known of its role in the pathogenesis of the neuronal complications…”
    Get more information
    Journal Article
  17. 17

    Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma by Patel, Y C, Ganda, O P, Benoit, R

    “…In the present study we characterized and compared the relative amounts of the different molecular forms of somatostatin-14 like immunoreactivity (S-14 LI) and…”
    Get more information
    Journal Article
  18. 18

    Studies on streptozotocin diabetes by Ganda, O. P., Rossini, A. A., Like, A. A.

    Published in Diabetes (New York, N.Y.) (01-07-1976)
    “…Studies on streptozotocin diabetes. O P Ganda , A A Rossini and A A Like Abstract Both alloxan and streptozotocin produce beta-cell necrosis in the rat…”
    Get full text
    Journal Article
  19. 19

    Diminished A-cell secretion in the early phase of type I diabetes mellitus by Ganda, O P, Srikanta, S, Gleason, R E, Soeldner, J S, Eisenbarth, G S

    Published in Metabolism, clinical and experimental (01-11-1986)
    “…The A-cell function in "true pre-type I diabetes" or in early phase of type I diabetes has not been reported. We studied A-cell reserve in response to…”
    Get more information
    Journal Article
  20. 20

    Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests by Ganda, O P, Day, J L, Soeldner, J S, Connon, J J, Gleason, R E

    Published in Diabetes (New York, N.Y.) (01-07-1978)
    “…We have developed a methodology for measuring the reproducibility of the oral glucose tolerance test (OGTT) and the intravenous glucose tolerance test (IVGTT)…”
    Get full text
    Journal Article